Skip to main content

Table 2 Comparison of mean scores of cognitive assessment scales between MS patients and healthy controls

From: Clinical predictors to cognitive impairment in multiple sclerosis patients

Mean ± SD

Patients (N = 45)

Controls (N = 45)

P value

ACE attention

16.7 ± 1.2

18.0 ± 0.0

< 0.001**

ACE memory

19.6 ± 2.3

24.5 ± 0.3

< 0.001**

ACE language

22.0 ± 2.3

25.2 ± 1.3

< 0.001**

ACE fluency

10.3 ± 1.7

12.6 ± 1.1

< 0.001**

ACE visuospatial

15.2 ± 1.1

16.0 ± 0.0

0.011*

ACE total

83.0 ± 5.7

95.5 ± 0. 4

< 0.001**

PASAT 3

21.9 ± 9.0

44.8 ± 7.8

< 0.001**

Trail making type B

191.3 ± 73.1

77.5 ± 6.0

< 0.001**

  1. *Significant
  2. **Highly significant
  3. ACE Addenbrooke’s cognitive examination III, PASAT3 Paced auditory serial addition test, N number, SD standard deviation
  4. P value is significant if ≤ 0.050